Small Pharma Stock Current Ratio

DMTTFDelisted Stock  USD 0.05  0.0009  1.80%   
Small Pharma fundamentals help investors to digest information that contributes to Small Pharma's financial success or failures. It also enables traders to predict the movement of Small OTC Stock. The fundamental analysis module provides a way to measure Small Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Small Pharma otc stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Small Pharma OTC Stock Current Ratio Analysis

Small Pharma's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

Current Ratio

 = 

Current Asset

Current Liabilities

More About Current Ratio | All Equity Analysis

Current Small Pharma Current Ratio

    
  6.62 X  
Most of Small Pharma's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Small Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Competition

In accordance with the recently published financial statements, Small Pharma has a Current Ratio of 6.62 times. This is 127.49% higher than that of the Healthcare sector and 5.43% lower than that of the Biotechnology industry. The current ratio for all United States stocks is notably lower than that of the firm.

Small Current Ratio Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Small Pharma's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Small Pharma could also be used in its relative valuation, which is a method of valuing Small Pharma by comparing valuation metrics of similar companies.
Small Pharma is currently under evaluation in current ratio category among its peers.

Small Fundamentals

About Small Pharma Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Small Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Small Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Small Pharma based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Consideration for investing in Small OTC Stock

If you are still planning to invest in Small Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Small Pharma's history and understand the potential risks before investing.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments